Lazard Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-59,432
| Closed | -$14.6M | – | 2629 |
|
|
2022
Q3 | $14.6M | Buy |
59,432
+2,713
| +5% | +$666K | 0.02% | 492 |
|
|
2022
Q2 | $14M | Buy |
56,719
+19,601
| +53% | +$4.85M | 0.02% | 521 |
|
|
2022
Q1 | $12.3M | Buy |
37,118
+8,901
| +32% | +$2.95M | 0.01% | 568 |
|
|
2021
Q4 | $10.1M | Buy |
28,217
+14,555
| +107% | +$5.23M | 0.01% | 625 |
|
|
2021
Q3 | $4.45M | Sell |
13,662
-565
| -4% | -$184K | 0.01% | 778 |
|
|
2021
Q2 | $4.44M | Buy |
14,227
+13,971
| +5,457% | +$4.36M | 0.01% | 739 |
|
|
2021
Q1 | $81K | Buy |
256
+12
| +5% | +$3.8K | ﹤0.01% | 1256 |
|
|
2020
Q4 | $79K | Buy |
+244
| New | +$79K | ﹤0.01% | 1239 |
|
|
2020
Q3 | – | Sell |
-539
| Closed | -$130K | – | 1782 |
|
|
2020
Q2 | $130K | Sell |
539
-410
| -43% | -$98.9K | ﹤0.01% | 969 |
|
|
2020
Q1 | $137K | Buy |
949
+419
| +79% | +$60.5K | ﹤0.01% | 954 |
|
|
2019
Q4 | $90K | Buy |
530
+399
| +305% | +$67.8K | ﹤0.01% | 974 |
|
|
2019
Q3 | $23K | Buy |
+131
| New | +$23K | ﹤0.01% | 1058 |
|
|
2019
Q2 | – | Sell |
-2,326
| Closed | -$664K | – | 1269 |
|
|
2019
Q1 | $664K | Buy |
+2,326
| New | +$664K | ﹤0.01% | 887 |
|
|
2016
Q1 | – | Sell |
-1,120
| Closed | -$101K | – | 1128 |
|
|
2015
Q4 | $101K | Buy |
1,120
+120
| +12% | +$10.8K | ﹤0.01% | 891 |
|
|
2015
Q3 | $92K | Sell |
1,000
-600
| -38% | -$55.2K | ﹤0.01% | 869 |
|
|
2015
Q2 | $105K | Buy |
+1,600
| New | +$105K | ﹤0.01% | 909 |
|